相关实验视频
Updated: Jul 25, 2025

07:50
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
5.6K
MGMT促进剂甲基化:超出治疗反应的预测
Keyoumars Ashkan1, Asfand Baig Mirza1, Christos Soumpasis1
1Kings College Hospital NHS Foundation Trust, Denmark Hill, London SE5 9RS, UK.
Journal of personalized medicine
|June 28, 2023
概括
较高的O6-甲基氨酸-DNA甲基转移酶 (MGMT) 促进剂甲基化与更好的质母细胞瘤结局相关. 这项研究表明,MGMT促进物甲基化是一个持续的预后因素,影响瘤体积,切除程度和生存率.
科学领域:
- 神经瘤学神经瘤学
- 分子诊断学 分子诊断
- 手术瘤学手术瘤学
背景情况:
- O6-甲基瓜因-DNA甲基转移酶 (MGMT) 促进剂甲基化是质母细胞瘤 (GBM) 治疗反应的关键生物标志物.
- 它在预测超出化疗敏感性的结果方面的作用需要进一步研究.
研究的目的:
- 探索MGMT促进物甲基化程度对接受5氨基利维氨酸 (5-ALA) 手术的GBM患者临床结果的影响.
- 为了确定MGMT促进物甲基化是否作为连续的预后变量.
主要方法:
- 对69名用5-ALA进行手术的GBM患者进行了回顾性单中心研究.
- 对人口统计,临床,组织学数据和生存率的评估.
- 对MGMT促进剂甲基化百分比与手术前瘤体积,5-ALA光,切除程度 (EoR) 和生存率 (PFS,OS) 的相关性分析.
主要成果:
- 较高的MGMT促进剂甲基化与较低的手术前瘤体积相关 (p=0.003),降低了5-ALA光度 (p=0.041),并增加了EoR (p=0.041).
- 升高的MGMT促进剂甲基化率与改善的无进展生存期 (PFS) (p=0.008) 和整体生存期 (OS) (p=0.006) 有显著的关联,即使在对EoR进行调整后.
- 更多的辅助化疗周期也预测了更长的PFS和OS.
结论:
- 应该将MGMT促进剂甲基化视为GBM的持续预后因素.
- 较高的甲基化百分比与有利的外科手术和生存结果有关,独立于化疗敏感性.
- 这一发现对质母细胞瘤个性化治疗策略有影响.
相关概念视频
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
Phase II Reactions: Methylation Reactions
240
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
240
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K

